Intelligence Platform
Patents
Browse 677 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6855323
Identification of the domain of Plasmodium falciparum erythrocyte membrane protein 1 (PfEM
expired patentUS 6852324
Immunization for ebola virus infection
expired patentUS 6852686
Methods for ameliorating icthyosiform skin diseases
expired patentUS 6849417
Mammalian selenoprotein differentially expressed in tumor cells
expired patentUS 6846911
Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammali
expired patentUS 6844190
St-B17 serotonin receptor
expired patentUS 6838237
Antigenically reactive regions of the hepatitis a virus polyprotein
expired patentUS 6838090
Water-insoluble drug delivery system
expired patentUS 6833128
Method for monitoring local reaction associated with injections
expired patentUS 6830893
T20/DP178 is an activator of human phagocyte formyl peptide receptors
expired patentUS 6828416
Recombinant multivalent malarial vaccine against Plasmodium falciparum
expired patentUS 6821511
Methods of using adeno-associated virus rep protein
expired patentUS 6818749
Variants of humanized anti carcinoma monoclonal antibody cc49
expired patentUS 6815173
Method for detecting syphilis using synthetic antigents
expired patentUS 6812246
Aminoflavone compounds, compositions, and methods of use thereof
expired patentUS 6808877
Ligands for FPR class receptors that induce a host immune response to a pathogen or inhibi
expired patentUS 6800475
Isolation of a human retrovirus
expired patentUS 6797275
Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccine
expired patentUS 6794498
Method of eliminating inhibitory/instability regions of mRNA
expired patentUS 6794188
Retrovirus vectors derived from avian sarcoma leukosis viruses permitting transfer of gene
expired patentUS 6794174
Full-length infectious cDNA clones of tick borne flavivirus
expired patentUS 6790449
Methods for producing self-replicating infectious RSV particles comprising recombinant RSV
expired patentUS 6790936
CAI resistance proteins and uses thereof
expired patentUS 6787333
Retrovirus isolated from humans
expired